Evidence map›Paper›PMID 35079946›Full record

ReviewMolecular diversity2022

Therapeutic potential of pyrrole and pyrrolidine analogs: an update.

N Jeelan Basha, S M Basavarajaiah, K Shyamsunder

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular diversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 173 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of the American Chemical Society · 2026
    Article
  4. Article
  5. Article
  6. Network Pharmacology-Guided Identification ofInternational journal of molecular sciences · 2026
    Article
  7. Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors.International journal of molecular sciences · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Advances in Mechanochemical Methods for One-Pot Multistep Organic Synthesis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Primary Pyrrolimines and Pyridinimines.Molecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

N Jeelan BashaDepartment of Chemistry, Indian Academy Degree College-Autonomous, Bengaluru, Karnataka, 560043, India. drjeelan@gmail.com.ORCID http://orcid.org/0000-0002-7979-8902
S M BasavarajaiahP.G. Department of Chemistry, Vijaya College, Bengaluru, Karnataka, 560004, India.
K ShyamsunderDepartment of Chemistry, Indian Academy Degree College-Autonomous, Bengaluru, Karnataka, 560043, India.
Indian Academy of Sciences · INVijaya College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemistry of nitrogen-containing heterocyclic compound pyrrole and pyrrolidine has been a versatile field of study for a long time for its diverse biological and medicinal importance. Biomolecules such as chlorophyll, hemoglobin, myoglobin, and cytochrome are naturally occurring metal complexes of pyrrole. These metal complexes play a vital role in a living system like photosynthesis, oxygen carrier, as well storage, and redox cycling reactions. Apart from this, many medicinal drugs are derived from either pyrrole, pyrrolidine, or by its fused analogs. This review mainly focuses on the therapeutic potential of pyrrole, pyrrolidine, and its fused analogs, more specifically anticancer, anti-inflammatory, antiviral, and antituberculosis. Further, this review summarizes more recent reports on the pyrrole, pyrrolidine analogs, and their biological potential.

Indexed as

Coordination ComplexesHeterocyclic CompoundsAnti-Inflammatory AgentsAntiviral AgentsChlorophyllCytochromesMyoglobinNitrogenOxygenPyrrolesPyrrolidinesAnti-Inflammatory AgentsAntiviral AgentsChlorophyllCoordination ComplexesCytochromesHeterocyclic CompoundsMyoglobinNitrogenOxygenPyrrolesPyrrolidinesAnticancerAnti-inflammatoryAntitubercular activityAnti-viralPyrrolePyrrolidine drugs

Identifiers

PMID35079946
PMCPMC8788913
OpenAlexW4206956500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.